Two Sigma Securities’s PDS Biotechnology PDSB Stock Holding History

Two Sigma Securities’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.5K	Buy	41,391 +9,910	+31%	+$10.5K	﹤0.01%	1424
2026 Q1	$19K	Buy	+31,481	New	+$23.7K	﹤0.01%	1376
2025 Q4	–	Sell	-14,149	Closed	-$14.3K	–	1883
2025 Q3	$14.3K	Sell	14,149 -8,479	-37%	-$9.97K	﹤0.01%	1180
2025 Q2	$30.1K	Buy	+22,628	New	+$30.7K	﹤0.01%	1153
2019 Q1	–	Sell	-1,222	Closed	-$8K	–	2279
2018 Q4	$8K	Buy	+1,222	New	+$16.2K	﹤0.01%	2036

Other funds holding PDSB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Two Sigma Securities's PDSB Position: Q2 2026 in Review

Two Sigma Securities increased its PDS Biotechnology (PDSB) stake by 31% in Q2 2026, buying an estimated $10.5K and bringing the position to 41,391 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

Two Sigma Securities first reported a position in PDSB in Q4 2018 and has held it in 5 quarters since. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

Two Sigma Securities held 41,391 shares of PDS Biotechnology worth $36.5K as of Q2 2026.
Two Sigma Securities bought 9,910 PDS Biotechnology shares in Q2 2026, an estimated $10.5K.
PDS Biotechnology made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1424 holding.
Two Sigma Securities first reported a position in PDS Biotechnology in Q4 2018 and has held it in 5 quarters since.
52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.